Literature DB >> 11812016

Vascular mechanisms in osteoarthritis.

P Ghosh1, P A Cheras.   

Abstract

Superficial injury and fibrillation of articular cartilage as a consequence of ageing, genetic, hormonal or mechanical factors are not necessarily associated with joint pain. However, failure of joint cartilage accompanied by synovitis and abnormalities in subchondral bone and its vasculature generally is, the syndrome being known as osteoarthritis. We suggest that the progression of early cartilage fibrillation to symptomatic OA arises initially as a consequence of the release into synovial fluid of cartilage-derived antigens that activate joint lining macrophages and circulating leukocytes, thereby establishing a synovitis. Pro-inflammatory mediators and pro-coagulant factors etc. not only perpetuate cartilage destruction but also promote a state of hypercoagulation, hypofibrinolysis, thrombosis and ischaemic bone necrosis at compromised sites such as in the subchondral vasculature. These events are augmented by ageing and associated hormonal changes. On the basis of this hypothesis we suggest that anti-thrombotic/anti-lipidaemic agents that also exhibit anti-inflammatory activity could be effective anti-osteoarthritic drugs. Experimental studies are described which support this proposal. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11812016     DOI: 10.1053/berh.2001.0188

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  24 in total

Review 1.  Is progressive osteoarthritis an atheromatous vascular disease?

Authors:  P G Conaghan; H Vanharanta; P A Dieppe
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

2.  The presence of total knee or hip replacements due to osteoarthritis enhances the positive association between hand osteoarthritis and atherosclerosis in women: the AGES-Reykjavik study.

Authors:  Helgi Jonsson; Gudrun P Helgadottir; Thor Aspelund; Gudny Eiriksdottir; Sigurdur Sigurdsson; Kristin Siggeirsdottir; Thorvaldur Ingvarsson; Tamara B Harris; Lenore Launer; Vilmundur Gudnason
Journal:  Ann Rheum Dis       Date:  2011-03-01       Impact factor: 19.103

3.  Effects of pentosan polysulfate in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled pilot study.

Authors:  Peter Ghosh; Jack Edelman; Lyn March; Margaret Smith
Journal:  Curr Ther Res Clin Exp       Date:  2005-11

4.  Transforming growth factor-beta2 suppresses collagen cleavage in cultured human osteoarthritic cartilage, reduces expression of genes associated with chondrocyte hypertrophy and degradation, and increases prostaglandin E(2) production.

Authors:  Elena V Tchetina; John Antoniou; Michael Tanzer; David J Zukor; A Robin Poole
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

5.  Hand osteoarthritis in relation to mortality and incidence of cardiovascular disease: data from the Framingham heart study.

Authors:  Ida K Haugen; Vasan S Ramachandran; Devyani Misra; Tuhina Neogi; Jingbo Niu; Tianzhong Yang; Yuqing Zhang; David T Felson
Journal:  Ann Rheum Dis       Date:  2013-09-18       Impact factor: 19.103

6.  MATN3 gene polymorphism is associated with osteoarthritis in Chinese Han population: a community-based case-control study.

Authors:  Jiaao Gu; Jiesheng Rong; Fulin Guan; Liying Jiang; Shuqing Tao; Guofa Guan; Tianzun Tao
Journal:  ScientificWorldJournal       Date:  2012-08-22

7.  Effects of hyaluronan on nitric oxide levels and superoxide dismutase activities in synovial fluid in knee osteoarthritis.

Authors:  Aydiner Kalaci; H Ramazan Yilmaz; Bahadir Aslan; Sadik Söğüt; Ahmet Nedim Yanat; Efkan Uz
Journal:  Clin Rheumatol       Date:  2006-12-20       Impact factor: 3.650

8.  Pentosan polysulfate promotes proliferation and chondrogenic differentiation of adult human bone marrow-derived mesenchymal precursor cells.

Authors:  Peter Ghosh; Jiehua Wu; Susan Shimmon; Andrew Cw Zannettino; Stan Gronthos; Silviu Itescu
Journal:  Arthritis Res Ther       Date:  2010-02-18       Impact factor: 5.156

9.  Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses.

Authors:  Edward H Schuchman; Yi Ge; Alon Lai; Yury Borisov; Meghan Faillace; Efrat Eliyahu; Xingxuan He; James Iatridis; Helen Vlassara; Gary Striker; Calogera M Simonaro
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

10.  Total cholesterol and triglycerides are associated with the development of new bone marrow lesions in asymptomatic middle-aged women - a prospective cohort study.

Authors:  Miranda L Davies-Tuck; Fahad Hanna; Susan R Davis; Robin J Bell; Sonia L Davison; Anita E Wluka; Jenny Adams; Flavia M Cicuttini
Journal:  Arthritis Res Ther       Date:  2009-12-04       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.